A case of multimodality multiparametric 11C-choline PET/MR for biopsy targeting in prior biopsy-negative primary prostate cancer

Clinical Nuclear Medicine

Volumn 37, Issue 9, 2012, Pages 918-919

  Takei, Toshiki ^a   Souvatzoglou, Michael ^a   Beer, Ambros J ^a   Drzezga, Alexander ^a   Ziegler, Sybille ^a   Rummeny, Ernst J ^a   Schwaiger, Markus ^a   Eiber, Matthias ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

11C choline PET; biopsy; PET MR; prostate cancer

Indexed keywords

CHOLINE C 11; PROSTATE SPECIFIC ANTIGEN;

AGED; ARTICLE; CASE REPORT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIMARY TUMOR; PROSTATE BIOPSY; PROSTATE CANCER; SOFT TISSUE;

AGED; BIOPSY; CARBON RADIOISOTOPES; CHOLINE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; POSITRON-EMISSION TOMOGRAPHY; PROSTATIC NEOPLASMS;

EID: 84865585595     PISSN: 03639762     EISSN: 15360229     Source Type: Journal    
DOI: 10.1097/RLU.0b013e31825b23a6     Document Type: Article

References (8)

1. Beer AJ, Eiber M, Souvatzoglou M, et al. Radionuclide and hybrid imaging of recurrent prostate cancer. Lancet Oncol. 2011;12:181-191.
2. Souvatzoglou M, Weirich G, Schwarzenboeck S, et al. The sensitivity of [11C]choline PET/CT to localize prostate cancer depends on the tumor configuration. Clin Cancer Res. 2011;17:3751-3759.
3. Testa C, Schiavina R, Lodi R, et al. Prostate cancer: sextant localization with MR imaging, MR spectroscopy, and 11C-choline PET/CT. Radiology. 2007;244: 797-806. (Pubitemid 47292091)
4. Fuchsjäger M, Shukla-Dave A, Akin O, et al. Prostate cancer imaging [review]. Acta Radiol. 2008;49:107-120.
5. Haider M, van der Kwast T, Tanguay J, et al. Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer. AJR. 2007;189: 323-328. (Pubitemid 47195916)
6. Park BK, Lee HM, Kim CK, et al. Lesion localization in patients with a previous negative transrectal ultrasound biopsy and persistently elevated prostate specific antigen level using diffusion-weighted imaging at three tesla before rebiopsy. Invest Radiol. 2008;43:789-793.
7. Alonzi R, Padhani AR, Allen C. Dynamic contrast enhanced MRI in prostate cancer. Eur J Radiol. 2007;63:335-350. (Pubitemid 47321040)
8. Scher B, Seitz M, Albinger W, et al. Value of 11C-choline PET and PET/CT in patients with suspected prostate cancer. Eur J Nucl Med Mol Imaging. 2007; 34:45-53. (Pubitemid 44885553)